For the first time, the effects of the Hsp90 inhibitor STA - 9090 (Ganetespib) were evaluated in an experimental mouse model of dinitrochlorobenzene (DNCB)-induced AD. This evidence concerns the gene HSP90AA1 and Alzheimer disease.